Safety and effectiveness of nafamostat mesylate in continuous renal replacement therapy in patients with sepsis-associated acute kidney injury: a prospective randomized controlled trial
To determine the safety and effectiveness of the anticoagulation regimen nafamostat mesylate for continuous renal replacement therapy in patients with sepsis-associated AKI.
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
De Gruyter
2026-02-01
|
| Schriftenreihe: | Open Medicine |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1515/med-2025-1369 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|